Erin E. Burkhart - 10 Mar 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: SVP, Controllership
Signature: /s/ Amy Kim by Power of Attorney for Erin E. Burkhart
Issuer symbol: GILD
Transactions as of: 10 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 12 Mar 2026, 16:37:46 UTC
Previous filing: 23 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Burkhart Erin	SVP, Controllership	333 LAKESIDE DRIVE, FOSTER CITY	/s/ Amy Kim by Power of Attorney for Erin E. Burkhart	12 Mar 2026	0001927648

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Award		+2,355	+26%		11,245	10 Mar 2026	Common Stock	2,355		Direct	F1, F2
transaction	GILD	Non-qualified Stock Option (Right to Buy)	Award		+5,455		$0.000000^*	5,455	10 Mar 2026	Common Stock	5,455	$148.56	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
F3	The stock options have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.